• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    NextCure, Inc. - Common Stock (NQ:NXTC)

    4.845 -0.235 (-4.63%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 29, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 55,401
    Open 5.000
    Bid (Size) 4.770 (300)
    Ask (Size) 4.920 (1,200)
    Prev. Close 5.080
    Today's Range 4.780 - 5.220
    52wk Range 1.550 - 15.74
    Shares Outstanding 2,676,110
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Get insights into the top gainers and losers of Friday's after-hours session. ↗
    Via Chartmill
    News headline image
    NextCure Provides Business Update and Reports Second Quarter 2026 Financial Results
    From NextCure
    Via GlobeNewswire

    Performance

    YTD
    -63.5%
    -63.5%
    1 Month
    -24.2%
    -24.2%
    3 Month
    +176.9%
    +176.9%
    6 Month
    -51.1%
    -51.1%
    1 Year
    -16.3%
    -16.3%

    More News

    Read More
    Top movers in Tuesday's session ↗
    Via Chartmill
    News headline image
    Halper Sadeh LLC is Investigating Whether VEEE, NXTC, TCBK, FHB are Obtaining Fair Deals for their Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    News headline image
    Shareholder Alert: Ademi LLP investigates whether NextCure, Inc. is obtaining a Fair Price for Public Shareholders
    From Ademi LLP
    Via GlobeNewswire
    In today's session, these stocks are experiencing unusual volume. ↗
    Via Chartmill
    These stocks are moving in today's after hours session ↗
    Via Chartmill
    Unusual volume stocks are being observed in Wednesday's session. ↗
    Via Chartmill
    Wednesday's pre-market session: top gainers and losers ↗
    Via Chartmill
    News headline image
    NXTC Stock Alert: Halper Sadeh LLC is Investigating Whether NextCure, Inc. is Obtaining a Fair Price for its Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    News headline image
    Kartoon Studios (NYSE: TOON) Enters Catalyst-Rich Growth Phase
    Via AB Newswire
    Topics Artificial Intelligence Intellectual Property
    Get insights into the top gainers and losers of Tuesday's after-hours session. ↗
    Via Chartmill
    News headline image
    Power Moves: NXTC, TOON, SHPH, COCH Entry Points Ignite on Major Catalysts
    Via AB Newswire
    Topics Artificial Intelligence
    Discover the most active stocks in Tuesday's session. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
    Via Benzinga
    News headline image
    NXTC Stock Alert: Halper Sadeh LLC is Investigating Whether NextCure, Inc. is Obtaining a Fair Price for its Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy
    From NextCure
    Via GlobeNewswire
    News headline image
    NXTC Announces Replay Available for Virtual KOL Event Discussing ASCO 2026 Dose Escalation Data from Phase 1 Trial of SIM0505 for Gynecologic Cancers
    From NextCure
    Via GlobeNewswire
    News headline image
    NextCure Presents Positive SIM0505 Phase 1 Dose Escalation Data in Patients with Gynecologic Cancers at ASCO 2026
    From NextCure
    Via GlobeNewswire
    News headline image
    NextCure Provides Business Update and Reports First Quarter 2026 Financial Results
    From NextCure
    Via GlobeNewswire
    News headline image
    NextCure and Simcere Zaiming Initiate Dose Optimization for SIM0505 (CDH6 ADC) in Gynecologic Cancers
    From NextCure
    Via GlobeNewswire
    News headline image
    NextCure and Simcere’s SIM0505 (CDH6 ADC) Phase 1 Data to be Presented at ASCO 2026
    From NextCure
    Via GlobeNewswire
    News headline image
    NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer
    From NextCure
    Via GlobeNewswire
    News headline image
    NextCure and Simcere’s SIM0505 (CDH6 ADC) Abstract Accepted for ASCO 2026
    From NextCure
    Via GlobeNewswire

    Frequently Asked Questions

    Is NextCure, Inc. - Common Stock publicly traded?
    Yes, NextCure, Inc. - Common Stock is publicly traded.
    What exchange does NextCure, Inc. - Common Stock trade on?
    NextCure, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for NextCure, Inc. - Common Stock?
    The ticker symbol for NextCure, Inc. - Common Stock is NXTC on the Nasdaq Stock Market
    What is the current price of NextCure, Inc. - Common Stock?
    The current price of NextCure, Inc. - Common Stock is 4.845
    When was NextCure, Inc. - Common Stock last traded?
    The last trade of NextCure, Inc. - Common Stock was at 09/29/26 04:00 PM ET
    What is the market capitalization of NextCure, Inc. - Common Stock?
    The market capitalization of NextCure, Inc. - Common Stock is 12.97M
    How many shares of NextCure, Inc. - Common Stock are outstanding?
    NextCure, Inc. - Common Stock has 13M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.